WHITNEY REED: Open Payments
NPI 1710361464 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 22 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $516 · 2025 $453
Food & beverage: $341Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $163 |
| ABBVIE INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Alkermes, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, COBENFY, UZEDY, CAPLYTA, INGREZZA, INVEGA SUSTENNA, ARISTADA.
Industry payments across AR — which companies pay providers there.
